Gernert, Michael
Tony, Hans-Peter
Schwaneck, Eva Christina
Gadeholt, Ottar
Schmalzing, Marc
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Funding program Open Access Publishing)
Article History
Received: 2 January 2019
Accepted: 2 April 2019
First Online: 29 April 2019
Ethics approval and consent to participate
: The study was approved by the local ethics committee of the University of Würzburg. All patients gave their written informed consent.
: Not applicable.
: MG received travel grants from AbbVie, Chugai, Janssen, Lilly, Pfizer, and Roche. H-PT received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Chugai/Roche, Janssen, Lilly, Novartis, Sandoz/Hexal, Sanofi Aventis, and Shire (Baxalta). ECS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Celgene, Chugai/Roche, Janssen-Cilag, Lilly, Novartis, and Shire (Baxalta). OG received compensation for board memberships from Novartis; speaker fees from AbbVie, Chugai, Janssen, Lilly, Novartis, and Sanofi; and travel grants from AbbVie, Chugai, Lilly, Janssen, Novartis, and MSD. MS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Actelion, BMS, Celgene, Chugai/Roche, Genzyme, Hexal/Sandoz, Janssen-Cilag, MSD, Novartis, Pfizer, Sanofi Pasteur, Shire (Baxalta), an UCB.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.